| Shelby Kaitlin Vaughan, | |
|
1045 Main St, Danville, VA 24541-1800 | |
| (434) 835-4765 | |
| Not Available |
| Full Name | Shelby Kaitlin Vaughan |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 1045 Main St, Danville, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144800186 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | 0701010320 (Virginia) | Primary |
| Entity Name | Danville Pittsylvania Community Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538120670 PECOS PAC ID: 6608760046 Enrollment ID: O20040209000535 |
News Archive
OPKO Health, Inc. (NYSE: OPK), a multi-national biopharmaceutical and diagnostics company, today announced that the Tel-Aviv Stock Exchange ("TASE") has approved the new listing of OPKO's common stock on the TASE beginning on August 21, 2013, under the ticker symbol OPK. OPKO's common stock will thereafter be listed on both the NYSE in the United States and the TASE in Israel.
InDepth Pharmaceuticals, founded by Deepak Nihalani, Ph.D., the SmartState Endowed Chair in Renal Disease Biomarkers at the Medical University of South Carolina, has taken a vital step toward commercializing an innovative diagnostic technique that could better predict kidney transplant success in patients with focal segmental glomerulosclerosis (FSGS), a kidney disease that often leads to end-stage renal failure.
Studying a protein that gives structure to the nucleus of cells, Johns Hopkins researchers stumbled upon mutations associated with familial partial lipodystrophy, a rare disease that disrupts normal patterns of fat distribution throughout the body.
A new study has shed light on the link between higher body mass index and serious health outcomes and death in over 2.8 million adults representative of the UK population.
Professor Clifford Hughes was speaking in anticipation of the publication of a White Paper published by the International Journal for Quality in Health Care (ISQua) today which discusses the impact of current and impending pressure of ageing populations which will present significant planning and budgetary challenges for global healthcare systems.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shelby Kaitlin Vaughan, 1045 Main St, Danville, VA 24541-1800 Ph: (434) 835-4765 | Shelby Kaitlin Vaughan, 1045 Main St, Danville, VA 24541-1800 Ph: (434) 835-4765 |
News Archive
OPKO Health, Inc. (NYSE: OPK), a multi-national biopharmaceutical and diagnostics company, today announced that the Tel-Aviv Stock Exchange ("TASE") has approved the new listing of OPKO's common stock on the TASE beginning on August 21, 2013, under the ticker symbol OPK. OPKO's common stock will thereafter be listed on both the NYSE in the United States and the TASE in Israel.
InDepth Pharmaceuticals, founded by Deepak Nihalani, Ph.D., the SmartState Endowed Chair in Renal Disease Biomarkers at the Medical University of South Carolina, has taken a vital step toward commercializing an innovative diagnostic technique that could better predict kidney transplant success in patients with focal segmental glomerulosclerosis (FSGS), a kidney disease that often leads to end-stage renal failure.
Studying a protein that gives structure to the nucleus of cells, Johns Hopkins researchers stumbled upon mutations associated with familial partial lipodystrophy, a rare disease that disrupts normal patterns of fat distribution throughout the body.
A new study has shed light on the link between higher body mass index and serious health outcomes and death in over 2.8 million adults representative of the UK population.
Professor Clifford Hughes was speaking in anticipation of the publication of a White Paper published by the International Journal for Quality in Health Care (ISQua) today which discusses the impact of current and impending pressure of ageing populations which will present significant planning and budgetary challenges for global healthcare systems.
› Verified 2 days ago
Anissa Howerton, Counselor Medicare: Not Enrolled in Medicare Practice Location: 150 W Main St, Danville, VA 24541 Phone: 434-239-0003 | |
Deshauna D Selby, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1555 Meadowview Dr, Danville, VA 24541 Phone: 800-805-6989 | |
Ms. Linda Giles, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 753 Main St Ste 1a, Danville, VA 24541 Phone: 434-799-2022 Fax: 434-799-2022 | |
Ms. Patricia Lynn Tompkins Woodson, M.ED.; LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1115 Franklin Tpke, Ak Ferrell Building, Suites 11 & 12, Danville, VA 24540 Phone: 434-836-6689 Fax: 434-685-1543 | |
Sierra Leann Hairston, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1555 Meadowview Dr Ste 5, Danville, VA 24541 Phone: 434-685-1570 | |
Chemieka Denise Lovelace, CSAC SUPERVISEE Counselor Medicare: Not Enrolled in Medicare Practice Location: 1555 Meadowview Dr Ste 7, Danville, VA 24541 Phone: 434-483-1545 Fax: 434-685-1470 | |
Joseph D Shelton, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 480 Mount Cross Rd, Danville, VA 24540 Phone: 513-834-7063 |